| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 26, 2024 | Sale | $425.70 | 5,034 | 2,142,974 | 49,691 | Feb 27, 2024, 04:37 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 23, 2024 | Option Exercise | $431.79 | 4,714 | 2,035,458 | 54,725 | Feb 27, 2024, 04:37 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 21, 2024 | Sale | $421.77 | 3,603 | 1,519,637 | 59,439 | Feb 23, 2024, 04:12 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 16, 2024 | Option Exercise | $424.01 | 4,499 | 1,907,621 | 71,219 | Feb 21, 2024, 04:19 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 20, 2024 | Sale | $420.70 | 8,177 | 3,440,091 | 67,846 | Feb 21, 2024, 04:19 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 12, 2024 | Sale | $420.24 | 4,295 | 1,804,931 | 75,718 | Feb 13, 2024, 04:51 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 09, 2024 | Option Exercise | $422.74 | 3,177 | 1,343,045 | 80,013 | Feb 13, 2024, 04:51 PM | |
| IMGN | ImmunoGen, Inc. | Arbuckle Stuart A | Director | Dec 29, 2023 | Option Exercise | $29.65 | 442 | 13,105 | 5,381 | Jan 03, 2024, 05:43 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Dec 13, 2023 | Option Exercise | $293.26 | 17,206 | 5,045,918 | 65,159 | Dec 15, 2023, 04:20 PM | |
| IMGN | ImmunoGen, Inc. | Arbuckle Stuart A | Director | Sep 29, 2023 | Option Exercise | $15.87 | 827 | 13,124 | 4,939 | Oct 02, 2023, 05:06 PM | |
| IMGN | ImmunoGen, Inc. | Arbuckle Stuart A | Director | Jun 30, 2023 | Option Exercise | $18.87 | 695 | 13,115 | 4,112 | Jul 05, 2023, 05:54 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Jun 15, 2023 | Option Exercise | $268.26 | 17,206 | 4,615,768 | 65,159 | Jun 20, 2023, 04:07 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | May 30, 2023 | Sale | $329.82 | 82 | 27,045 | 56,556 | Jun 01, 2023, 04:16 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 24, 2023 | Option Exercise | $289.12 | 4,714 | 1,362,912 | 61,590 | Feb 28, 2023, 04:47 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 27, 2023 | Sale | $287.47 | 5,034 | 1,447,143 | 57,756 | Feb 28, 2023, 04:47 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 22, 2023 | Sale | $294.33 | 2,401 | 706,679 | 68,576 | Feb 24, 2023, 04:06 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 21, 2023 | Sale | $293.75 | 2,402 | 705,596 | 71,086 | Feb 22, 2023, 04:30 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 17, 2023 | Option Exercise | $292.85 | 4,498 | 1,317,239 | 71,107 | Feb 22, 2023, 04:30 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 14, 2023 | Sale | $298.68 | 6,398 | 1,910,962 | 81,203 | Feb 16, 2023, 04:14 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 10, 2023 | Option Exercise | $294.33 | 3,372 | 992,481 | 92,880 | Feb 14, 2023, 04:53 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 13, 2023 | Sale | $298.56 | 10,877 | 3,247,393 | 86,890 | Feb 14, 2023, 04:53 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Aug 15, 2022 | Sale | $270.01 | 28,744 | 7,761,241 | 67,451 | Aug 17, 2022, 05:39 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Aug 10, 2022 | Sale | $262.42 | 244 | 64,029 | 61,060 | Aug 12, 2022, 04:05 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Aug 09, 2022 | Sale | $263.98 | 7,616 | 2,010,445 | 66,686 | Aug 10, 2022, 04:06 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | May 16, 2022 | Sale | $251.19 | 133 | 33,408 | 64,882 | May 18, 2022, 04:21 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | May 02, 2022 | Sale | $263.98 | 306 | 80,778 | 64,760 | May 04, 2022, 05:21 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 24, 2022 | Option Exercise | $227.86 | 7,246 | 1,651,074 | 65,066 | Feb 28, 2022, 05:19 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 17, 2022 | Option Exercise | $232.51 | 4,126 | 959,336 | 72,312 | Feb 22, 2022, 04:54 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 10, 2022 | Option Exercise | $237.74 | 3,040 | 722,730 | 76,438 | Feb 14, 2022, 04:13 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Nov 15, 2021 | Sale | $187.26 | 3 | 562 | 41,104 | Nov 16, 2021, 04:05 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 24, 2021 | Option Exercise | $217.57 | 2,898 | 630,518 | 44,737 | Feb 26, 2021, 04:07 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 25, 2021 | Sale | $213.54 | 3,634 | 775,989 | 44,357 | Feb 26, 2021, 04:07 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 17, 2021 | Option Exercise | $211.75 | 6,240 | 1,321,320 | 55,460 | Feb 19, 2021, 04:08 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 18, 2021 | Sale | $211.82 | 7,825 | 1,657,481 | 54,438 | Feb 19, 2021, 04:08 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 11, 2021 | Sale | $210.55 | 5,156 | 1,085,593 | 62,500 | Feb 16, 2021, 04:07 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 10, 2021 | Option Exercise | $214.16 | 3,101 | 664,110 | 66,856 | Feb 12, 2021, 04:04 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 03, 2021 | Sale | $150.13 | 3,108 | 466,598 | 71,511 | Feb 05, 2021, 04:43 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Nov 16, 2020 | Sale | $223.64 | 7 | 1,565 | 35,184 | Nov 18, 2020, 04:11 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Nov 03, 2020 | Option Exercise | $149.22 | 3,106 | 463,481 | 36,732 | Nov 05, 2020, 04:16 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Aug 03, 2020 | Sale | $182.45 | 3,106 | 566,702 | 36,732 | Aug 05, 2020, 04:17 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Jul 07, 2020 | Sale | $236.76 | 5,572 | 1,319,203 | 37,965 | Jul 09, 2020, 04:13 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | May 15, 2020 | Sale | $283.98 | 113 | 32,089 | 35,282 | May 19, 2020, 04:22 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | May 04, 2020 | Sale | $173.64 | 3,106 | 539,322 | 36,732 | May 06, 2020, 04:38 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 24, 2020 | Option Exercise | $239.23 | 2,898 | 693,289 | 38,813 | Feb 26, 2020, 04:30 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 25, 2020 | Sale | $233.74 | 3,634 | 849,418 | 38,003 | Feb 26, 2020, 04:30 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 17, 2020 | Option Exercise | $241.50 | 2,496 | 602,784 | 44,839 | Feb 19, 2020, 04:32 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 18, 2020 | Sale | $243.56 | 3,128 | 761,842 | 44,079 | Feb 19, 2020, 04:32 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 11, 2020 | Sale | $246.09 | 11,286 | 2,777,325 | 57,691 | Feb 12, 2020, 05:13 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 10, 2020 | Option Exercise | $240.95 | 8,942 | 2,154,575 | 58,621 | Feb 12, 2020, 05:13 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 06, 2020 | Option Exercise | $206.46 | 5,574 | 1,150,812 | 70,350 | Feb 07, 2020, 04:08 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Jan 31, 2020 | Sale | $213.09 | 9,384 | 1,999,637 | 37,932 | Feb 04, 2020, 04:10 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, Chief Commercial Officer | Feb 03, 2020 | Sale | $160.14 | 7,420 | 1,188,221 | 36,950 | Feb 04, 2020, 04:10 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 15, 2019 | Sale | $205.95 | 19 | 3,913 | 33,240 | Nov 19, 2019, 04:09 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 13, 2019 | Option Exercise | $180.57 | 17,120 | 3,091,359 | 41,800 | Nov 15, 2019, 04:03 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 04, 2019 | Option Exercise | $145.39 | 7,416 | 1,078,185 | 35,395 | Nov 06, 2019, 04:11 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Aug 08, 2019 | Sale | $156.89 | 4,250 | 666,782 | 35,365 | Aug 12, 2019, 04:14 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Aug 02, 2019 | Sale | $134.42 | 4,310 | 579,329 | 34,395 | Aug 06, 2019, 04:41 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Aug 05, 2019 | Sale | $131.48 | 3,106 | 408,377 | 33,793 | Aug 06, 2019, 04:41 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jun 19, 2019 | Sale | $156.89 | 4,250 | 666,782 | 35,365 | Jun 20, 2019, 04:53 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | May 15, 2019 | Sale | $165.41 | 133 | 22,000 | 33,240 | May 17, 2019, 04:18 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | May 02, 2019 | Sale | $130.16 | 4,310 | 560,980 | 35,395 | May 06, 2019, 04:06 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | May 03, 2019 | Sale | $129.46 | 3,106 | 402,089 | 34,793 | May 06, 2019, 04:06 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Apr 15, 2019 | Sale | $181.75 | 5,624 | 1,022,148 | 36,272 | Apr 17, 2019, 04:30 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Feb 11, 2019 | Sale | $180.21 | 33,073 | 5,959,969 | 61,280 | Feb 13, 2019, 04:37 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Feb 04, 2019 | Sale | $160.07 | 26,268 | 4,204,740 | 54,711 | Feb 06, 2019, 04:50 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jan 22, 2019 | Option Exercise | $162.68 | 4,250 | 691,411 | 48,877 | Jan 24, 2019, 04:46 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 15, 2018 | Sale | $163.75 | 29 | 4,749 | 46,752 | Nov 19, 2018, 05:28 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 07, 2018 | Option Exercise | $155.44 | 4,250 | 660,641 | 48,877 | Nov 08, 2018, 04:26 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 05, 2018 | Option Exercise | $137.58 | 11,606 | 1,596,791 | 51,002 | Nov 06, 2018, 04:24 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 02, 2018 | Option Exercise | $133.21 | 4,310 | 574,114 | 48,907 | Nov 05, 2018, 04:52 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Aug 02, 2018 | Sale | $144.05 | 8,560 | 1,233,095 | 48,907 | Aug 06, 2018, 05:21 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Aug 03, 2018 | Option Exercise | $138.64 | 11,606 | 1,609,093 | 52,555 | Aug 06, 2018, 05:21 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jul 13, 2018 | Option Exercise | $155.44 | 12,750 | 1,981,924 | 53,127 | Jul 17, 2018, 06:23 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jul 16, 2018 | Option Exercise | $138.36 | 4,250 | 588,030 | 48,877 | Jul 17, 2018, 06:23 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jun 29, 2018 | Option Exercise | $129.08 | 7,416 | 957,230 | 50,460 | Jul 03, 2018, 12:00 AM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jun 22, 2018 | Sale | $134.07 | 8,500 | 1,139,595 | 51,002 | Jun 26, 2018, 05:20 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | May 15, 2018 | Sale | $155.78 | 138 | 21,498 | 46,752 | May 16, 2018, 05:11 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Apr 16, 2018 | Option Exercise | $129.94 | 4,250 | 552,245 | 48,877 | Apr 18, 2018, 02:50 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Feb 26, 2018 | Sale | $153.00 | 8,013 | 1,226,023 | 53,211 | Feb 28, 2018, 09:22 AM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Feb 13, 2018 | Sale | $151.83 | 4,044 | 614,000 | 53,679 | Feb 15, 2018, 04:23 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Feb 12, 2018 | Sale | $152.82 | 6,824 | 1,042,833 | 61,650 | Feb 14, 2018, 06:16 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Feb 05, 2018 | Sale | $128.15 | 17,000 | 2,178,593 | 50,452 | Feb 07, 2018, 05:46 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Feb 02, 2018 | Option Exercise | $130.24 | 4,312 | 561,573 | 44,108 | Feb 05, 2018, 05:11 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jan 24, 2018 | Option Exercise | $128.85 | 17,938 | 2,311,283 | 50,921 | Jan 26, 2018, 04:46 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jan 16, 2018 | Option Exercise | $127.58 | 4,250 | 542,194 | 44,077 | Jan 17, 2018, 04:34 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jan 11, 2018 | Option Exercise | $134.07 | 8,500 | 1,139,595 | 46,202 | Jan 12, 2018, 04:16 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 15, 2017 | Sale | $147.29 | 48 | 7,070 | 41,952 | Dec 06, 2017, 05:40 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 15, 2017 | Sale | $147.29 | 221 | 32,551 | 41,952 | Nov 17, 2017, 04:37 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Nov 06, 2017 | Option Exercise | $112.74 | 8,500 | 958,290 | 46,202 | Nov 07, 2017, 05:15 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Oct 31, 2017 | Sale | $144.81 | 75,000 | 10,860,645 | 105,335 | Oct 31, 2017, 06:16 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Oct 27, 2017 | Sale | $132.08 | 8,415 | 1,111,446 | 119,077 | Oct 31, 2017, 06:16 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Aug 07, 2017 | Option Exercise | $115.10 | 8,500 | 978,308 | 125,367 | Aug 09, 2017, 04:36 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Aug 03, 2017 | Option Exercise | $132.43 | 8,500 | 1,125,655 | 125,367 | Aug 04, 2017, 04:53 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jul 31, 2017 | Option Exercise | $118.18 | 4,250 | 502,244 | 123,242 | Aug 02, 2017, 04:44 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jul 19, 2017 | Sale | $134.39 | 178,800 | 24,029,548 | 220,867 | Jul 21, 2017, 07:58 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jul 21, 2017 | Sale | $156.95 | 14,600 | 2,291,537 | 133,592 | Jul 21, 2017, 07:58 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jun 01, 2017 | Option Exercise | $88.87 | 27,188 | 2,416,198 | 145,061 | Jun 05, 2017, 06:06 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Jun 02, 2017 | Sale | $104.85 | 114,750 | 12,031,028 | 188,842 | Jun 05, 2017, 06:06 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Apr 28, 2017 | Option Exercise | $82.31 | 56,640 | 4,661,755 | 159,567 | May 02, 2017, 05:17 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVPChief Commercial Officer | Feb 13, 2017 | Sale | $88.39 | 3,792 | 335,175 | 127,455 | Feb 15, 2017, 04:47 PM |
Menu